Quick Takeaways
- Paradigm Biocapital Advisors LP filed SCHEDULE 13G/A for Disc Medicine, Inc. Common Stock, $0.0001 par value per share (IRON).
- Disclosed ownership: 3.5%.
- Date of event: 31 Mar 2025.
Paradigm Biocapital Advisors LP - 31 Mar 2025 SCHEDULE 13G/A Report for Disc Medicine, Inc. Common Stock, $0.0001 par value per share (IRON)
- Filing Manager
- Paradigm Biocapital Advisors LP
- Reporting Manager
- Paradigm BioCapital Advisors LP
- Symbol
- IRON
- Shares outstanding
- 34,599,171 shares
- Disclosed Ownership
- 1,210,971 shares
- Ownership
- 3.5%
- Form type
- SCHEDULE 13G/A
- Filing time
- 15 May 2025, 16:40:31 UTC
- Date of event
- 31 Mar 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Paradigm Biocapital Advisors LP disclosed 3.5% ownership in Disc Medicine, Inc. Common Stock, $0.0001 par value per share (IRON) on 31 Mar 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 15 May 2025, 16:40.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Paradigm BioCapital Advisors LP | 3.5% | 1,210,971 | 1,210,971 | 0 | /s/ David K. Kim | David K. Kim / Authorized Signatory | |
| Paradigm BioCapital Advisors GP LLC | 3.5% | 1,210,971 | 1,210,971 | 0 | /s/ David K. Kim | David K. Kim / Authorized Signatory | |
| Senai Asefaw, M.D. | 3.5% | 1,210,971 | 1,210,971 | 0 | /s/ Senai Asefaw, M.D. | N/A | |
| Paradigm BioCapital International Fund Ltd. | 3.1% | 1,069,143 | 1,069,143 | 0 | /s/ David K. Kim | David K. Kim / Authorized Signatory |